Trademarkia Logo

Canada

C$
Trademark Search in Canada
CHEMOMAB

View On IC.GC.CA

CHEMOMAB
REGISTERED

on 20 Sept 2023

Last Applicant/ Owned by

CHEMOMAB THERAPEUTICS LTD.

Kiryat Atidim, Building 7, P.O.B. 58288 6158002 Tel Aviv - Yafo

IL

Serial Number

2170205 filed on 9th Jan 2022

Registration Number

TMA1199294 registered on 20th Sept 2023

Registration expiry Date

9th Jan 2032

Correspondent Address

MBM INTELLECTUAL PROPERTY AGENCY

275 SLATER STREET14TH FLOOROTTAWA

ONTARIO

CA

K1P5H9

CHEMOMAB

Trademark usage description

pharmaceutical and medicinal products for the treatment of inflammatory, fibrotic, and autoimmune diseases. providing medical research information, n Read More

Classification Information

Class [005]
Pharmaceutical and medicinal products for the treatment of inflammatory, fibrotic, and autoimmune diseases.

Classification kind code

11

Class [042]
Providing medical research information, namely, biological, chemical, pharmaceutical, and clinical data in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals for treatment of fibrotic diseases, autoimmune diseases, and inflammatory diseases; research and development of pharmaceuticals for the treatment of fibrotic diseases, inflammatory diseases, autoimmune diseases.

Classification kind code

11

Mark Details

Serial Number

2170205

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 26
on 5th Jun 2023		Approved
Submitted for opposition 22
on 30th May 2023		Search Recorded
Submitted for opposition 256
on 3rd Jan 2023		Notification of Possible Opposition Sent
Submitted for opposition 67
on 30th Dec 2022		Agent Name Changed
Submitted for opposition 48
on 16th Sept 2022		Agent Changed
Submitted for opposition 257
on 3rd Mar 2022		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 2th Mar 2022		Formalized
Submitted for opposition 1
on 2th Mar 2022		Created
Submitted for opposition 228
on 9th Jan 2022		International Registration
Submitted for opposition 30
on 9th Jan 2022		Filed